Statistics

Total Visits

Views
A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143)103

Select a period of time:

Number of views in the range

Views
A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143)28

Views

Views
November 20252
December 20251
January 20263
February 20260
March 20266
April 20269
May 20267
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States8
Finland3
United Kingdom3
Colombia3
Turkey2
Mexico2
Canada1
Switzerland1
Chile1
Spain1
 

Top cities views

Views
Helsinki3
Adana1
Almansa1
Annapolis1
Antalya1
Atlanta1
Beachwood1
Bogotá1
Chennai1
Grajales1